An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial - Saraf, Amit; Gurjar, Rohan; Kaviraj, Swarnendu; Kulkarni, Aishwarya; Kumar, Durgesh; Kulkarni, Ruta; Virkar, Rashmi; Krishnan, Jayashri; Yadav, Anjali; Baranwal, Ekta; Singh, Ajay; Raghuwanshi, Arjun; et al. (Nature Medicine, 2024)